NCT04622878

Brief Summary

Acute limb ischemia (ALI) is a sudden decrease in limb perfusion due to either an embolic or a thrombotic vascular occlusion, defined as the presence of symptoms within two weeks of onset. The profound ischemia represents an emergency in which delayed treatment results in limb loss and, potentially, death. Therefore, timely diagnosis and proper treatments for ALI are important. Both surgical thrombectomy and endovascular treatment have benefits and drawbacks. Surgical thrombectomy using Fogarty embolectomy catheter has been the standard therapy because it is rapid and effective in cases of embolic ALI. However, blind surgical thrombectomy can result in poor revascularization or unexpected vascular injury in the presence of underlying arterial atherosclerosis or in the presence of subacute and chronic thrombi. In addition, thrombosis of runoff vessels is difficult to remove. Endovascular management using catheter-directed thrombolysis (CDT) has emerged as an alternative to surgery. It is less invasive, and does not directly damage the vascular endothelium with the capacity to clear thrombus in the small vessels. However, long treatment duration may worsen the clinical situation. Besides, a thrombus of more than two weeks does not respond well to the thrombolysis, and it is difficult to determine the exact stage of thrombus according to the clinical history. These problems may be minimized by combined treatment, which includes surgical thrombectomy and endovascular treatment.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2020

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 27, 2020

Completed
1 month until next milestone

First Posted

Study publicly available on registry

November 10, 2020

Completed
21 days until next milestone

Study Start

First participant enrolled

December 1, 2020

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
Last Updated

November 13, 2020

Status Verified

November 1, 2020

Enrollment Period

1 year

First QC Date

September 27, 2020

Last Update Submit

November 10, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • limb salvage

    Technical success rates is defined as patency of the treated vessel segment with less than 20 % residual stenosis , without dissection and restoration of in line flow to foot , weight and height of the pt will be combined to report BMI kg/m\^2

    immediately post operative

Study Arms (1)

acute lower limb ischemia patients

OTHER

patients with no palpable pulsations or audible signals in the lower limb

Procedure: thrombectomy and PTA

Interventions

open femoral access with fogarty catheter then PTA with balloon and possible stenting if needed

acute lower limb ischemia patients

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with acute onset of lower limb pain with various degrees of movement compromise.
  • History of intermittent claudication with a sudden worsening of claudication and pain at rest for less than one month.
  • Patients with Duplex or MSCT angiography of the lower limbs showing embolic events on healthy vessels or thrombosis of diseased vessels with or without collateralization.
  • Thrombus in a poor location that is difficult to be removed by surgical thrombectomy alone.
  • Acute lower limb ischemia due to acute arterial graft occlusion

You may not qualify if:

  • \- Medically compromised patients, not fit for the intervention.
  • Patients with critical chronic limb ischemia (grade III, IV).
  • Patients with known vasculitis or lab investigations suggesting vasculitis before treating the cause.
  • Patients who refused the intervention.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, Jones DN. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg. 1997 Sep;26(3):517-38. doi: 10.1016/s0741-5214(97)70045-4.

    PMID: 9308598BACKGROUND
  • Kashyap VS, Gilani R, Bena JF, Bannazadeh M, Sarac TP. Endovascular therapy for acute limb ischemia. J Vasc Surg. 2011 Feb;53(2):340-6. doi: 10.1016/j.jvs.2010.08.064. Epub 2010 Nov 3.

    PMID: 21050699BACKGROUND

MeSH Terms

Interventions

Thrombectomy

Intervention Hierarchy (Ancestors)

Vascular Surgical ProceduresCardiovascular Surgical ProceduresSurgical Procedures, Operative

Central Study Contacts

kerolos Raafat khalil Gad Basta, resident

CONTACT

Ahmed khairy, lecturer

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident physician at vascular surgery department ، Assiut University

Study Record Dates

First Submitted

September 27, 2020

First Posted

November 10, 2020

Study Start

December 1, 2020

Primary Completion

December 1, 2021

Study Completion

December 31, 2021

Last Updated

November 13, 2020

Record last verified: 2020-11